![](https://cdn.prod.website-files.com/664356b5a2e4f1e357ace733/67079aeaccef56d3024c5795_HIF%20Page%20picture.webp)
Add impact to your portfolio with our latest fund
We are NLC Health Ventures — a world-leading healthtech venture builder and early-stage investor. Our purpose is to bring science to life by bridging the gap between scientific discoveries and market-ready solutions that transform patients’ lives.
Our expertise
Our impact
1,500
Inventions assessed annually
100+
Ventures built
247K
Patients impacted
4
Captive funds
80+
Healthcare experts
€135M+
Raised by NLC ventures
Explore our 2023 Impact report
![Woman with hands in the air in nature](https://cdn.prod.website-files.com/664356b5a2e4f1e357ace733/6655f8079499fd8cf6aed6b7_oma3.webp)
![BioScience Valuation](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f37b67f33fb538d4f8a33_download.webp)
![Terumo](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f2a5b96892335d85d2f89_Terumo.svg.webp)
![Imperial King's College](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f117e9505c06d362b3e38_Imperial_College_London_new_logo.webp)
![VGZ](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f11a0706435d01f0f7c34_Logo%20Cooperatie%20VGZ%20850x850.webp)
![Mayo Clinic](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f11ee86e3e1b2b67baa05_Mayo_Clinic_logo.svg.webp)
![Oxford](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f121b6d192771b42277fb_University_of_Oxford.svg.webp)
![NHS](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f12441db19bf32f73e839_National_Health_Service_(England)_logo.svg.webp)
![Charite](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f14304c11c69caeaf8292_Logo_Charite.svg.webp)
![Google](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664de91f9fad0ccb1bf04c69_uc.webp)
![BioCurate](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/66535e8dc77b0e3cd17f15f8_BioCurate.webp)
![GE](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f29ba96892335d85c4cfa_General_Electric_logo.svg.webp)
![Medtronic](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664de91df5090d200fea6dec_uc.webp)
![Philips](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f2a0baa8dce230fff0570_Philips_logo_new.svg.webp)
![Stryker](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f2a2276d1f14090649cbe_Stryker_Corporation_logo.svg.webp)
I recognize that progress in life sciences and health requires collaborative co-creation. Success hinges on understanding field needs, evaluating products and synthesizing strategies from diverse perspectives. Working with experts is therefore key and this is where NLC excels.
![Andras Heijink](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f18c7b77c156b3a930b3e_andras.webp)
Andras Heijink
MD, PhD, MBA, Orthopedic Surgeon, Musculoskeletal Expert Panel Member at NLC
After my journey as founder of Novamedia/Postcode Lotteries, I founded Phase2.earth, which invested in NLC in 2021. I've since witnessed the remarkable growth and recommend anyone who seeks to combine a significant positive impact with a sound investment to come on board.
![Boudewijn Poelmann](https://cdn.prod.website-files.com/66436b3334541a4f2174a307/664f18aa5cbff7d2a6801dc6_small%20b.webp)
Boudewijn Poelmann
Founder of Novamedia/Postcode Lotteries and founder Phase2.earth